Victoria Rollason
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban.
Journal: British journal of clinical pharmacology
Published: July 09, 2024
Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population.
Journal: British journal of clinical pharmacology
Published: May 20, 2024
The treatment of behavioural and psychological symptoms in dementia: pragmatic recommendations.
Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
Published: November 15, 2023
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 16, 2023
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 10, 2023
Reproductive Safety of Trazodone After Maternal Exposure in Early Pregnancy: A Comparative ENTIS Cohort Study.
Journal: Journal of clinical psychopharmacology
Published: December 30, 2022
Practice of CYP450 genotyping and phenotyping in children in a real-life setting.
Journal: Frontiers in pharmacology
Published: December 22, 2022
Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans.
Journal: Genome biology and evolution
Published: November 22, 2022
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting.
Journal: Journal of personalized medicine
Published: February 22, 2022
Last Updated: 09/26/2026